| Business Name: |
Youngblood Kneeland C MD |
| Contact Person: |
Kneeland Youngblood |
| Address: |
300 Crescent Court # 1380, Dallas, Texas 75201 |
| Phone Number: |
(214) 855-0194 |
| Website Address: |
pharosfunds.com |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Kim Jong - Dallas, TX 75201
Gagnon Garry MD - Dallas, TX 75201
Rhea Dalton MD - Dallas, TX 75201
Corwin Shawn MD - Dallas, TX 75201
Leeanne Harshman Md Pllc - Dallas, TX 75201
Worthy R Warnack Md - Dallas, TX 75201
Sharp Thomas L DO - Dallas, TX 75201
Mark L Lemmon Md - Dallas, TX 75201
Cimarron Biomedical Investors L P - Dallas, TX 75201
Dr Craig Speight - Dallas, TX 75201
Dr Thomas P Lohmann - Dallas, TX 75201
Dr Kathleen E Vandiver - Dallas, TX 75201
Dr Rubin Velez - Dallas, TX 75201
Jeremy E Alperin Md - Dallas, TX 75201
Robert D Grooss Dr - Dallas, TX 75201
Nichelle Wiggins - Dallas, TX 75201
Flanary Group - Dallas, TX 75201
Jeffrey M Harvey Pc - Dallas, TX 75201
Garman John L DO - Dallas, TX 75201
Vankawala Hemant MD - Dallas, TX 75201
|
The company Youngblood Kneeland C MD provides B2C services in the form of Doctors from its single location in Texas.
1 to 4 employees work for Youngblood Kneeland C MD, and the business now earns $500.000 to $999.999 per annum.
Youngblood Kneeland C MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Youngblood Kneeland C MD, please call Kneeland Youngblood with the phone number (214) 855-0194 or visit its single location at 300 Crescent Court # 1380 in Dallas, Texas 75201.
The location of the single location can also be found using the coordinates 32.79402,-96.803936.
Read more details about this business on the webpage pharosfunds.com or follow the company’s social media accounts, on Twitter and on Facebook.